Treating Systolic Hypertension in the Very Elderly With Valsartan‐Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results

J Clin Hypertens (Greenwich). 2011;13:722–730. ©2011 Wiley Periodicals, Inc.

[1]  D. Kereiakes,et al.  The Effects of an Olmesartan Medoxomil–Based Treatment Algorithm on 24‐Hour Blood Pressure Levels in Elderly Patients Aged 65 and Older , 2009, Journal of clinical hypertension.

[2]  M. Vandervoort,et al.  A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster Randomized, Controlled Trial , 2009, Hypertension.

[3]  P. Gorelick,et al.  Management of hypertension and cerebrovascular disease in the elderly. , 2008, The American journal of medicine.

[4]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[5]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension , 2007, Blood pressure.

[6]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[7]  M. Weir,et al.  Evaluation of the Dose Response With Valsartan and Valsartan/Hydrochlorothiazide in Patients With Essential Hypertension , 2007, Journal of clinical hypertension.

[8]  J. Izzo,et al.  Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study , 2007, Journal of clinical hypertension.

[9]  C. Lau,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2007, Hypertension.

[10]  J. Izzo,et al.  Titration of HCTZ to 50 mg Daily in Individuals With Stage 2 Systolic Hypertension Pretreated With an Angiotensin Receptor Blocker , 2007, Journal of clinical hypertension.

[11]  P. Ridker,et al.  Valsartan, Blood Pressure Reduction, and C-Reactive Protein: Primary Report of the Val-MARC Trial , 2006, Hypertension.

[12]  S. Neldam,et al.  Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study. , 2006, The American journal of geriatric cardiology.

[13]  Y. Lacourciére,et al.  Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. , 2005, Clinical therapeutics.

[14]  Morris J. Brown,et al.  British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary , 2004, BMJ : British Medical Journal.

[15]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[16]  P. Palatini,et al.  A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study. , 2003, Clinical therapeutics.

[17]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[18]  J. Sanderson,et al.  Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension. , 2003, Clinical therapeutics.

[19]  J. Mallion,et al.  Valsartan/Hydrochlorothiazide is Effective in Hypertensive Patients Inadequately Controlled by Valsartan Monotherapy , 2003, Blood pressure. Supplement.

[20]  W. Cushman,et al.  The Effect of a Losartan‐Based Treatment Regimen on Isolated Systolic Hypertension , 2002, Journal of clinical hypertension.

[21]  J. García-Puig,et al.  The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension , 2000 .

[22]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[23]  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. , 1985, British medical journal.

[24]  P. Weidmann,et al.  Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension. , 1978, Kidney international.

[25]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .

[26]  J. García-Puig,et al.  The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group. , 2000, Journal of hypertension.

[27]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.